The DOI matches its Crossref record; the references it cites are not checked yet.
Iatrogenic Cushing Syndrome in a Child With Congenital Adrenal Hyperplasia: Erroneous Compounding of Hydrocortisone
Abstract
Context: Patients with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH) require lifelong treatment with glucocorticoids. In growing children, the drug of choice is hydrocortisone. Commercially available hydrocortisone tablets do not conform to very low doses prescribed to infants and toddlers, and compounded hydrocortisone is often dispensed to meet therapeutic needs. However, safety, efficacy, and uniformity of compounded products are not tested. We report a case of Cushing syndrome in a child with CAH who was inadvertently receiving excessive hydrocortisone in compounded form. Design: A 20-month-old girl with CAH developed growth deceleration, excessive weight for length, irritability, increased facial fat, plethora, and excess body hair while receiving hydrocortisone from a local compounding pharmacy. The signs and symptoms persisted despite decreasing hydrocortisone dose. Iatrogenic Cushing syndrome was suspected. The prescribed hydrocortisone capsules were sent for analysis to the Sports Medicine Research & Testing Laboratory, where testing revealed that each 1-mg hydrocortisone capsule contained five to 10 times the dose prescribed and listed on the label. Conclusion: Physicians must be aware that errors in compounded medications may lead to unanticipated adverse effects. Iatrogenic Cushing syndrome should be suspected in any child receiving compounded glucocorticoid treatment who develops growth arrest and excess weight gain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to classic CAH, no general guidelines exist for the management and follow-up of these patients and the overall evidence of recommendations for NC CAH is low (134,342,417-419).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [342]
In the citing paper
“Criteria defining a comprehensive expert level of care for CAH have been published(342,738).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [342]
In the citing paper
“Availability of pediatric dose formulations would eliminate concerns about improper compounding of HC from tablets (192)(193)(194).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [194]
In the citing paper
“The inconsistency in hydrocortisone dose created by compounding can lead to severe clinical consequences with poor disease control due to undertreatment (7) and Cushings syndrome due to overtreatment (11,12).”
From Immediate-release granule formulation of hydrocortisone, Alkindi®, for treatment of paediatric adrenal insufficiency (Infacort development programme) (2018) · cites this paper as [11]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 11 · Cited by 35
Metadata
- Authors
- Barillas, J. E., Eichner, D., Van Wagoner, R., & Speiser, P. W.
- Affiliations
- Cohen Children's Medical Center (US)
- Hofstra University (US)
- Corresponding author
- Speiser, Phyllis W
- ORCID
- Speiser, Phyllis W
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-09-28
- Volume
- 103
- Issue
- 1
- Pages
- 7-11
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2760621886
- Cited by
- 35
- References
- 11
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 1 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 6
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- iatrogenic Cushing's syndrome, congenital adrenal hyperplasia, 21-hydroxylase deficiency, cortisol, compounded medications, pediatric patients, growth arrest, weight gain, compounding pharmacies
- MeSH terms
- Adrenal Hyperplasia, Congenital, Anti-Inflammatory Agents, Cushing Syndrome, Female, Humans, Hydrocortisone, Iatrogenic Disease, Infant, Medication Errors, Prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Iatrogenic Cushing Syndrome in a Child With Congenital Adrenal Hyperplasia: Erroneous Compounding of Hydrocortisone. https://app.cochat.ai/papers/10.1210/jc.2017-01595
- The paper
- Barillas, J. E., Eichner, D., Van Wagoner, R., & Speiser, P. W. (2018). Iatrogenic Cushing Syndrome in a Child With Congenital Adrenal Hyperplasia: Erroneous Compounding of Hydrocortisone. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2017-01595
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.